loader
Please Wait
Applying Filters...

Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X

End Use API: CAS 86087-23-2

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Malladi Drugs & Pharmaceuticals Limited (2)

02 Sigmak Lifesciences (1)

03 Porton Pharma Solutions (5)

04 Anvitha Lifecare (1)

05 Enzymaster (Ningbo) Bio-Engineering (2)

06 Guangzhou Topwork Chemical (4)

07 Jiangsu Yutian Pharmaceutical Co., Ltd (1)

08 Nanjing Lift Pharmaceutical Technology Co., Ltd (2)

09 Ningbo Zhenlei Chemical Co.,Ltd (1)

10 Octane Laboratories (1)

11 SS Pharma (1)

12 Shanghai Fine Pharma (1)

13 Visa Chem (1)

14 Zenfold Sustainable Technologies (1)

86087-23-2
S-(+)-3-Hydroxytetrahydrofuran
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few ...
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few years, Malladi established itself as a leader in manufacturing ephedrine and pseudoephedrine salts. Today, it is the leading manufacturer of APIs in the cough and cold segment. It also has a dominant presence in several therapeutic segments like antihistamines, anti-convulsants, anti-depressants and anxiolytics (CNS). Malladi exports its products to around 60 countries and over 85% of its revenue is generated from exports. Its manufacturing facilities have been approved by the FDA, EDQM, KFDA, TGA and various other regulatory agencies.
Malladi Company Banner

PharmaLytica 2024

Not Confirmed

envelop Contact Supplier
86087-23-2
S-(+)-3-Hydroxytetrahydrofuran
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few ...
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few years, Malladi established itself as a leader in manufacturing ephedrine and pseudoephedrine salts. Today, it is the leading manufacturer of APIs in the cough and cold segment. It also has a dominant presence in several therapeutic segments like antihistamines, anti-convulsants, anti-depressants and anxiolytics (CNS). Malladi exports its products to around 60 countries and over 85% of its revenue is generated from exports. Its manufacturing facilities have been approved by the FDA, EDQM, KFDA, TGA and various other regulatory agencies.
Malladi Company Banner

PharmaLytica 2024

Not Confirmed

envelop Contact Supplier
86087-23-2
Sigmak Lifesciences is a leading contract manufacturer, merchant exporter, & distributor of pharmaceutica...
Sigmak Lifesciences is a leading contract manufacturer, merchant exporter, & distributor of pharmaceutical APIs & Fine Chemicals. We excel in Contract Manufacturing, covering a wide spectrum of intermediates, including advance intermediates, cGMP, & non-GMP intermediates. We represent GMP and WHO-certified manufacturers of APIs & advanced intermediates, offering Distribution & Agency services with rigorous selection processes & regular audits to guarantee top-quality products. Moreover, our global Strategic Sourcing capabilities provide high-quality ingredients & performance chemicals to the Pharmaceuticals & Specialty Chemical Industries.
Sigmak Lifesciences CB

PharmaLytica 2024

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
86087-23-2
(S)-3-hydroxytetyrahydrofuran
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzh...
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
Porton Company Banner

PharmaLytica 2024

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
86087-23-2
(S)-3-hydroxytetyrahydrofuran
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzh...
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
Porton Company Banner

PharmaLytica 2024

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
86087-23-2
(S)-3-hydroxytetyrahydrofuran
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzh...
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
Porton Company Banner

PharmaLytica 2024

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
86087-23-2
(S)-3-hydroxytetyrahydrofuran
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzh...
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
Porton Company Banner

PharmaLytica 2024

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
86087-23-2
(S)-3-hydroxytetyrahydrofuran
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzh...
Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
Porton Company Banner

PharmaLytica 2024

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
127852-28-2
Established in 2016, a state-of-the-art R&D facility engaged in the development of Novel processes for Bu...
Established in 2016, a state-of-the-art R&D facility engaged in the development of Novel processes for Bulk Actives including Deuterated Actives, Advanced Intermediates and up the value chain. With experience, Anvitha Life Care Private Limited has knowledge and expertise as a leader in chemical research. Every decision is inspired by our main mission, which is to provide the highest standard of product and services to our clients. In this rapidly changing industry, we’ve realized the importance of continually updating our approach to stay relevant in the market, and are committed to just that.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
86087-23-2
(S)-3-Hydroxytetrahydrofuran
Based on the excellent enzymatic technology platform, Enzymaster Chemical applies innovative technology t...
Based on the excellent enzymatic technology platform, Enzymaster Chemical applies innovative technology to realize its commercial production of chiral compounds.As a wholly-owned subsidiary of Enzymaster®, we think globally and devote to supply high quality chemical products, which are sustainable supply, with eco-friendly process and competitive price.Meanwhile, we provide domestic and overseas customers biocatalytic custom synthesis serves.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY